0001437749-22-013129.txt : 20220519
0001437749-22-013129.hdr.sgml : 20220519
20220519204011
ACCESSION NUMBER: 0001437749-22-013129
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220517
FILED AS OF DATE: 20220519
DATE AS OF CHANGE: 20220519
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Buller Richard E
CENTRAL INDEX KEY: 0001688319
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38207
FILM NUMBER: 22945007
MAIL ADDRESS:
STREET 1: C/O CELCUITY INC.
STREET 2: 16305 36TH AVE. N., #100
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55446
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celcuity Inc.
CENTRAL INDEX KEY: 0001603454
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 16305 36TH AVENUE N
STREET 2: SUITE 100
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55446
BUSINESS PHONE: 763-392-0767
MAIL ADDRESS:
STREET 1: 16305 36TH AVENUE N
STREET 2: SUITE 100
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55446
FORMER COMPANY:
FORMER CONFORMED NAME: Celcuity LLC
DATE OF NAME CHANGE: 20140324
4
1
rdgdoc.xml
FORM 4
X0306
4
2022-05-17
0001603454
Celcuity Inc.
CELC
0001688319
Buller Richard E
16305 36TH AVENUE NORTH
SUITE 100
MINNEAPOLIS
MN
55446
1
Common Stock
2022-05-17
4
A
0
3273
0
A
11798
D
Stock Option (right to buy)
10.68
2022-05-17
4
D
0
4555
D
2029-12-03
Common Stock
4555
0
D
Stock Option (right to buy)
5.50
2022-05-17
4
A
0
4555
A
2029-12-03
Common Stock
4555
4555
D
Stock Option (right to buy)
26.99
2022-05-17
4
D
0
2310
D
2031-05-12
Common Stock
2310
0
D
Stock Option (right to buy)
5.50
2022-05-17
4
A
0
2310
A
2031-05-12
Common Stock
2310
2310
D
Stock Option (right to buy)
5.1000
2030-05-14
Common Stock
12654
12654
D
Stock Option (right to buy)
5.50
2022-05-17
4
A
0
19558
0
A
2032-05-17
Common Stock
19558
19558
D
Represents 3,273 shares of restricted stock for which risks of forfeiture lapse on April 30, 2023, or if earlier, the date of the Company's 2023 Annual Meeting of Stockholders.
100% vested.
This Option will vest and become exercisable on April 30, 2023, or if earlier, the date of the Company's 2023 Annual Meeting of Stockholders.
The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option.
/s/ Eric O. Madson as Attorney-in-Fact for Richard E. Buller pursuant to Power of Attorney previously filed.
2022-05-19